Skip to Content

SGX942 Approval Status

FDA Approved: No
Brand name: SGX942
Generic name: dusquetide
Company: Soligenix, Inc.
Treatment for: Mucositis

SGX942 (dusquetide) is an innate defense regulator (IDR) in development for the treatment of oral mucositis.

Development Status and FDA Approval Process for SGX942

DateArticle
Aug 18, 2016FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
Jun  3, 2013FDA Grants Soligenix "Fast Track" Designation for SGX942 for the Treatment of Oral Mucositis in Patients with Head and Neck Cancer

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide